Procedure
Peripheral blood stem cell infusion
Peripheral blood stem cell infusion is a medical procedure with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
1(17%)
Results Posted
60%(3 trials)
Phase Distribution
Ph not_applicable
1
17%
Ph phase_1
3
50%
Ph phase_2
2
33%
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
1(16.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(5)
Detailed Status
Completed5
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (50.0%)
Phase 22 (33.3%)
N/A1 (16.7%)
Trials by Status
recruiting117%
completed583%
Recent Activity
1 active trials
Showing 5 of 6
completedphase_2
N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
NCT00253435
recruitingphase_1
Stem Cell Transplantation in Crohn's Disease
NCT04224558
completedphase_1
N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma
NCT01019850
completedphase_1
N99-02: Melphalan and Buthionine Sulfoximine
NCT00005835
completednot_applicable
Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies
NCT00476229
Clinical Trials (6)
Showing 6 of 6 trials
NCT00253435Phase 2
N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
NCT04224558Phase 1
Stem Cell Transplantation in Crohn's Disease
NCT01019850Phase 1
N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma
NCT00005835Phase 1
N99-02: Melphalan and Buthionine Sulfoximine
NCT00476229Not Applicable
Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies
NCT00427557Phase 2
Cellular Therapy With Cord Blood Cells
All 6 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 6